Yuanjun Lu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Viral-associated cancers and disorders
Papers in
-
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 4
- Immunology 10
- Immune cells in cancer 7
- Co-authors
- Ning Wang (24 shared papers)Yibin Feng (22 shared papers)Yau-Tuen Chan (18 shared papers)Hor‐Yue Tan (11 shared papers)Sha Li (1 shared paper)Cheng Zhang (14 shared papers)Guiyuan Li (6 shared papers)Zailong Qin (6 shared papers)
- Journals
- Journal of Advanced Research (3 papers)Frontiers in Cell and Developmental Biology (2 papers)Frontiers in Immunology (2 papers)Molecular Cancer (2 papers)International Journal of Biological Sciences (2 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Yuanjun Lu
39 papers receiving 1.6k citations
Yuanjun Lu's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 436
- Oncology 332
- Molecular Biology 761
- Immunology 194
- Pulmonary and Respiratory Medicine 195
Countries citing papers authored by Yuanjun Lu
This map shows the geographic impact of Yuanjun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanjun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanjun Lu more than expected).
Fields of papers citing papers by Yuanjun Lu
This network shows the impact of papers produced by Yuanjun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanjun Lu. The network helps show where Yuanjun Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuanjun Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy Hit paper breakdown → | 2020 | 343 |
| 2 | Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma Hit paper breakdown → | 2022 | 150 |
| 3 | 2017 | 103 | |
| 4 | 2018 | 86 | |
| 5 | 2017 | 75 | |
| 6 | 2022 | 59 | |
| 7 | 2014 | 57 | |
| 8 | 2022 | 55 | |
| 9 | 2016 | 54 | |
| 10 | 2019 | 47 | |
| 11 | 2023 | 46 | |
| 12 | 2021 | 46 | |
| 13 | 2022 | 43 | |
| 14 | 2017 | 39 | |
| 15 | 2023 | 39 | |
| 16 | 2022 | 35 | |
| 17 | 2024 | 35 | |
| 18 | 2023 | 34 | |
| 19 | 2023 | 31 | |
| 20 | 2013 | 30 |
About Yuanjun Lu
Yuanjun Lu is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Cancer Cells and Metastasis (4 papers), Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers), MicroRNA in disease regulation (4 papers), Ferroptosis and cancer prognosis (3 papers), Viral-associated cancers and disorders (3 papers) and Electrocatalysts for Energy Conversion (3 papers). The work is most often cited by research in Cancer Research (436 citations), Oncology (332 citations), Molecular Biology (761 citations), Immunology (194 citations) and Pulmonary and Respiratory Medicine (195 citations). Yuanjun Lu has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Ning Wang, Yibin Feng, Yau-Tuen Chan, Hor‐Yue Tan, Sha Li, Cheng Zhang, Guiyuan Li, Zailong Qin, Jian Ma and Lingyu Wei. Their work appears in journals such as Journal of Advanced Research, Frontiers in Cell and Developmental Biology, Frontiers in Immunology, Molecular Cancer and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.